Daniel is an associate in our corporate department.
Daniel advises entrepreneurs, startups, established corporations and venture and private equity funds on raising financing, strategic investments, mergers and share and asset acquisitions.
Daniel further provides legal counsel on various commercial activities, including license, franchise, distribution and manufacturing agreements.
Before joining Barnea, Daniel worked in a leading Israeli law firm.
Tel Aviv University (LL.B, English Literature), 2014
Member of the Israel Bar Association since 2014
News and updates - Daniel Arbov:
Barnea Represented CryoLife in a Strategic Transaction with the Israeli Medtech Startup Endospan
Our firm represented CryoLife in a strategic transaction with Israel-based endovascular stent graft system developer Endospan. The transaction involved an option to purchase Endospan for up to USD 450 million in the future, together with an exclusive distribution arrangement and USD 15 million in secured debt financing.
Barnea Represented Johnson & Johnson Innovation in an Investment Round in DayTwo
Our firm represented JJDC in its follow on investment in the Israeli medtech company DayTwo, as part of a $31 million series B round.